Emerging Co-signaling Networks in T Cell Immune Regulation

키워드

참고문헌 (99)

1. Van Parijs, L., "Homeostasis and self-tolerance in the immune system: turning lymphocytes off", Science, 280, pp.243~248 (1998)
2. Chen, L., "Molecular mechanisms of T cell co-stimulation and co-inhibition", Nat. Rev. Immunol, 13, pp.227~242 (2013)
3. Pardoll, D. M, "The blockade of immune checkpoints in cancer immunotherapy", Nat. Rev. Cancer, 12, pp.252~264 (2012)
4. Saito, T., "Dynamic regulation of T cell activation and co-stimulation through TCR-microclusters", FEBS Lett, 584, pp.4865~4871 (2010)
5. Greenwald, R. J., "The B7 family revisited", Annu. Rev. Immunol, 23, pp.515~548 (2005)
6. Isakov, N., "PKC-theta-mediated signal delivery from the TCR", CD28 surface receptors, 2012, pp.3, 273~
7. Rudd, C. E., "Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling", Nat. Rev. Immunol, 3, pp.544~556 (2003)
8. Viola, A., "T cell activation determined by T cell receptor number and tunable thresholds", Science, 273, pp.104~106 (1996)
9. Boise, L. H., "CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL", Immunity, 3, pp.87~98 (1995)
10. Rulifson, I. C., "CD28 costimulation promotes the production of Th2 cytokines", J. Immunol, 158, pp.658~665 (1997)
11. Zhang, R., "An obligate cell-intrinsic function for CD28 in Tregs", J. Clin. Invest, 123, pp.580~593 (2013)
12. Walunas, T. L., "CTLA-4 can function as a negative regulator of T cell activation", Immunity, 1, pp.405~413 (1994)
13. Salama, A. K, "Cytotoxic T-lymphocyte- associated antigen-4", Clin. Cancer Res, 17, pp.4622~4628 (2011)
14. Qureshi, O. S., "Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4", Science, 332, pp.600~603 (2011)
15. Hori, S., "Control of regulatory T cell development by the transcription factor Foxp3", Science, 299, pp.1057~1061 (2003)
16. Fontenot, J. D., "Foxp3 programs the development and function of CD4＋CD25＋ regulatory T cells", Nat. Immunol, 4, pp.330~336 (2003)
17. Paust, S., "Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease", Proc. Natl. Acad. Sci. USA, 101, pp.10398~10403 (2004)
18. Grohmann, U., "CTLA-4-Ig regulates tryptophan catabolism in vivo", Nat. Immunol, 3, pp.1097~1101 (2002)
19. Fallarino, F., "Modulation of tryptophan catabolism by regulatory T cells", Nat. Immunol, 4, pp.1206~1212 (2003)
20. Munn, D. H., "Ligation of B7-1", B7-2 by human CD4＋ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells, 2004, pp.172, 4100~4110
21. Keir, M. E., "PD-1 and its ligands in tolerance and immunity", Annu. Rev. Immunol, 26, pp.677~704 (2008)
22. Butte, M. J., "Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses", Immunity, 27, pp.111~122 (2007)
23. Shlapatska, L. M., "CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A", J. Immunol, 166, pp.5480~5487 (2001)
24. Agata, Y., "Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes", Int. Immunol, 8, pp.765~772 (1996)
25. Dong, H., "Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion", Nat. Med, 8, pp.793~800 (2002)
26. Blank, C., "PD-L1", B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8＋ T cells, 2004, pp.64, 1140~1145
27. Taube, J. M., "Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape", Sci. Transl. Med, 4, pp.127ra137~ (2012)
28. Thompson, R. H., "Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow- up", Cancer Res, 66, pp.3381~3385 (2006)
29. Boland, J. M., "Tumor B7-H1 and B7-H3 expression in squamous cell carcinoma of the lung", Clin. Lung Cancer, 14, pp.157~163 (2013)
30. Mu, C. Y., "High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation", Med. Oncol, 28, pp.682~688 (2011)
31. Wang, L., "Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma", World J. Surg, 34, pp.1059~1065 (2010)
32. Nakanishi, J., "Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers", Cancer Immunol. Immunother, 56, pp.1173~1182 (2007)
33. Barber, D. L., "Restoring function in exhausted CD8 T cells during chronic viral infection", Nature, 439, pp.682~687 (2006)
34. Day, C. L., "PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression", Nature, 443, pp.350~354 (2006)
35. West, E. E., "PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells", J. Clin. Invest, 123, pp.2604~2615 (2013)
36. Shin, T., "In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses", J. Exp. Med, 201, pp.1531~1541 (2005)
37. Dong, H., "B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion", Nat. Med, 5, pp.1365~1369 (1999)
38. Francisco, L. M., "PD-L1 regulates the development, maintenance, and function of induced regulatory T cells", J. Exp. Med, 206, pp.3015~3029 (2009)
39. Gajewski, T. F., "Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy", Cancer J, 16, pp.399~403 (2010)
40. Brahmer, J. R., "Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates", J. Clin. Oncol, 28, pp.3167~3175 (2010)
41. van Elsas, A., "Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte", macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation, 1999, pp.190, 355~366
42. Li, B., "Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors", Clin. Cancer Res, 15, pp.1623~1634 (2009)
43. Swallow, M. M., "B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha", Immunity, 11, pp.423~432 (1999)
44. Ling, V., "Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor", J. Immunol, 164, pp.1653~1657 (2000)
45. Yoshinaga, S. K., "T-cell co-stimulation through B7RP-1 and ICOS", Nature, 402, pp.827~832 (1999)
46. Aicher, A., "Characterization of human inducible costimulator ligand expression and function", J. Immunol, 164, pp.4689~4696 (2000)
47. Nakazawa, A., "The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells", Gastroenterology, 126, pp.1347~1357 (2004)
48. Wiendl, H., "Muscle fibres and cultured muscle cells express the B7.1", 2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies, 2003, pp.126, 1026~1035
49. Brodie, D., "LICOS, a primordial costimulatory ligand?", Curr. Biol, 10, pp.333~336 (2000)
50. Wang, S., "Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS", Blood, 96, pp.2808~2813 (2000)
51. Beier, K. C., "Induction, binding specificity and function of human ICOS", Eur. J. Immunol, 30, pp.3707~3717 (2000)
52. Mages, H. W., "Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand", Eur. J. Immunol, 30, pp.1040~1047 (2000)
53. Yoshinaga, S. K., "Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS", Int. Immunol, 12, pp.1439~1447 (2000)
54. Coyle, A. J., "The CD28-related molecule ICOS is required for effective T cell-dependent immune responses", Immunity, 13, pp.95~105 (2000)
55. Sharpe, A. H., "The B7-CD28 superfamily", Nat. Rev. Immunol, 2, pp.116~126 (2002)
56. Kopf, M., "Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection", J. Exp. Med, 192, pp.53~61 (2000)
57. Sperling, A. I., "ICOS costimulation: is it the key to selective immunotherapy?", Clin. Immunol, 100, pp.261~262 (2001)
58. Akbari, O., "Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity", Nat. Med, 8, pp.1024~1032 (2002)
59. Riella, L. V., "B7h (ICOS-L) maintains tolerance at the fetomaternal interface", Am. J. Pathol, 182, pp.2204~2213 (2013)
60. Hu, Y. L., "B7RP-1 blockade ameliorates autoimmunity through regulation of follicular helper T cells", J. Immunol, 182, pp.1421~1428 (2009)
61. Yao, S., "B7-h2 is a costimulatory ligand for CD28 in human", Immunity, 34, pp.729~740 (2011)
62. Chapoval, A. I., "B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production", Nat. Immunol, 2, pp.269~274 (2001)
63. Sun, M., "Characterization of mouse and human B7-H3 genes", J. Immunol, 168, pp.6294~6297 (2002)
64. Steinberger, P., "Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains", J. Immunol, 172, pp.2352~2359 (2004)
65. Xu, H., "MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors", Cancer Res, 69, pp.6275~6281 (2009)
66. Chen, C., "Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response", Exp. Cell Res, 319, pp.96~102 (2013)
67. Zhao, X., "B7-H3 overexpression in pancreatic cancer promotes tumor progression", Int. J. Mol. Med, 31, pp.283~291 (2013)
68. Zhang, G., "Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum", Immunology, 123, pp.538~546 (2008)
69. Chen, X., "Circulating B7-H3(CD276) elevations in cerebrospinal fluid and plasma of children with bacterial meningitis", J. Mol. Neurosci, 37, pp.86~94 (2009)
70. Zhang, G., "B7-H3 augments the inflammatory response and is associated with human sepsis", J. Immunol, 185, pp.3677~3684 (2010)
71. Hashiguchi, M., "Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses", Proc. Natl. Acad. Sci. USA, 105, pp.10495~10500 (2008)
72. Brunner, A., "Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis", Gynecol. Oncol, 124, pp.105~111 (2012)
73. Sun, J., "Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma", Cancer Immunol. Immunother, 59, pp.1163~1171 (2010)
74. Katayama, A., "Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis", Int. J. Oncol, 38, pp.1219~1226 (2011)
75. Sica, G. L., "B7-H4, a molecule of the B7 family, negatively regulates T cell immunity", Immunity, 18, pp.849~861 (2003)
76. Prasad, D. V., "B7S1, a novel B7 family member that negatively regulates T cell activation", Immunity, 18, pp.863~873 (2003)
77. Mugler, K. C., "B7-h4 expression in a range of breast pathology: correlation with tumor T-cell infiltration", Appl. Immunohistochem. Mol. Morphol, 15, pp.363~370 (2007)
78. Li, Z. Y., "Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors", Onco. Targets Ther, 6, pp.869~875 (2013)
79. Zhu, J., "B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer", Asian Pac. J. Cancer Prev, 14, pp.3011~3015 (2013)
80. Fauci, J. M., "A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer", Gynecol Oncol, 127, pp.420~425 (2012)
81. Chen, L. J., "B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma", Cancer Immunol. Immunother, 60, pp.1047~1055 (2011)
82. Kryczek, I., "B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma", J. Exp. Med, 203, pp.871~881 (2006)
83. Zhu, G., "B7-H4-deficient mice display augmented neutrophilmediated innate immunity", Blood, 113, pp.1759~1767 (2009)
84. Qian, Y., "B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells", Cell Tissue Res, 353, pp.139~151 (2013)
85. Cheng, L., "B7-H4 expression promotes tumorigenesis in ovarian cancer", Int. J. Gynecol. Cancer, 19, pp.1481~1486 (2009)
86. Zhang, L., "The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus", Oncogene (2013)
87. Wang, L., "VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses", J. Exp. Med, 208, pp.577~592 (2011)
88. Ceeraz, S., "B7 family checkpoint regulators in immune regulation and disease", Trends Immunol (2013)
89. Sakr, M. A., "GI24 enhances tumor invasiveness by regulating cell surface membrane-type 1 matrix metalloproteinase", Cancer Sci, 101, pp.2368~2374 (2010)
90. Aloia, L., "Differentiation of embryonic stem cells 1 (Dies1) is a component of bone morphogenetic protein 4 (BMP4) signaling pathway required for proper differentiation of mouse embryonic stem cells", J. Biol. Chem, 285, pp.7776~7783 (2010)
91. Brandt, C. S., "The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans", J. Exp. Med, 206, pp.1495~1503 (2009)
92. Fiegler, N., "Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells", Blood, 122, pp.684~693 (2013)
93. Pogge von Strandmann, E., "Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells", Immunity, 27, pp.965~974 (2007)
94. Sasaki, T., "HLA-B-associated transcript 3 (Bat3)", Scythe is essential for p300-mediated acetylation of p53, 2007, pp.21, 848~861
95. Correia, D. V., "Differentiation of human peripheral blood Vdelta1＋ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells", Blood, 118, pp.992~1001 (2011)
96. Delahaye, N. F., "Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors", Nat. Med, 17, pp.700~707 (2011)
97. Mager, D. L., "Endogenous retroviruses provide the primary polyadenylation signal for two new human genes (HHLA2 and HHLA3)", Genomics, 59, pp.255~263 (1999)
98. Flajnik, M. F., "Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC", Immunogenetics, 64, pp.571~590 (2012)
99. Zhu, Y., "B7-H5 costimulates human T cells via CD28H", Nat. Commun, 4, pp.2043~ (2013)

관련 논문AI추천